Prakt. lékáren. 2018; 14(3): 132-134 | DOI: 10.36290/lek.2018.026

Gymnena sylvestre in a therapy of diabetes mellitus

Zdeňka Navrátilová
Katedra botaniky, Přírodovědecká fakulta UK Praha

Gymnema sylvestre, also known as gurmar, is an evergreen climber originated in tropical Asia, Africa and Australia. It has been usedfor centuries in traditional ayurvedic medicine for treatment of many illnesses, such as diabetes, obesity, malaria, skin diseases,asthma, cough, inflammations, infections, and snakebite. The research has identified the main active components as oleanan- anddammarane‑typetriterpenic saponins (gymnemic acids, gymnemasaponins, and gymnemosides). Antidiabetic and hypolipidemiceffects were confirmed in animal studies and clinical trials, further research continues.

Keywords: Gymnema sylvestre, gurmar, diabetes, herbal remedies

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátilová Z. Gymnena sylvestre in a therapy of diabetes mellitus. Praktické lékárenství. 2018;14(3):132-134. doi: 10.36290/lek.2018.026.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Lášticová M. Léčba diabetu 2. typu v ordinaci praktického lékaře. Med praxi. 2013; 10(6-7): 223-225.
    2. Koupý D, Rudá-Kučerová J. Účinnost fytoterapie v léčbě diabetes mellitus 2. typu. Interní Med. 2015; 17(5): 240-242.
    3. Zhengyi W, Raven P. Flora of China Vol. 16: Gentianaceae through Boraginaceae. Missouri Botanical Garden Press 1995. 479 p.
    4. Pothuraju R, Sharma RK, Chagalamarri J, Jangra S, Kumar Kavadi P. A systematic review of Gymnema sylvestre in obesity and diabetes management. J Sci Food Agric. 2014; 94(5): 834-840. Go to original source... Go to PubMed...
    5. Khare CP. Indian Herbal Remedies: Rational Western Therapy, Ayurvedic and Other Traditional Usage, Botany. Springer 2012. 524 p.
    6. Braun L, Cohen M. Herbs & Natural Supplements - An Evidence-Based Guide 3rd ed. Churchill Livingstone 2010. 900 p.
    7. Tiwari P, Mishra BN, Sangwan NS. Phytochemical and pharmacological properties of Gymnema sylvestre: an important medicinal plant. Biomed Res Int. 2014; 2014: 830285. Go to original source... Go to PubMed...
    8. Porchezhian E, Dobriyal RM. An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents. Pharmazie. 2003; 58(1): 5-12. Go to original source... Go to PubMed...
    9. Ulbricht C, Abrams TR, Basch E, Davies-Heerema T, Foppa I, Hammerness P, Rusie E, Tanguay-Colucci S, Taylor S, Ulbricht C, Varghese M, Weissner W, Woods J. An evidence-based systematic review of gymnema (Gymnema sylvestre R. Br.) by the Natural Standard Research Collaboration. J Diet Suppl. 2011; 8(3): 311-330. Go to original source... Go to PubMed...
    10. Singh DK, Kumar N, Sachan A, Lakhani P, Tutu S, Nath R, Sachan AK, Dixit RK. Hypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar Rats. J Clin Diagn Res. 2017; 11(5): FF01-FF05. Go to original source...
    11. Khare AK, Tondon RN, Tewari JP. Hypoglycaemic activity of an indigenous drug (Gymnema sylvestre,, Gurmar) in normal and diabetic persons. Indian J Physiol Pharmacol. 1983; 27(3): 257-258.
    12. Shanmugasundaram ER, Rajeswari G, Baskaran K, Rajesh Kumar BR, Radha Shanmugasundaram K, Kizar Ahmath B. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol. 1990; 30(3): 281-194. Go to original source... Go to PubMed...
    13. Leach MJ. Gymnema sylvestre for diabetes mellitus: a systematic review. J Altern Complement Med. 2007; 13(9): 977-983. Go to original source... Go to PubMed...
    14. Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990; 30(3): 295-300. Go to original source... Go to PubMed...
    15. Woodgate DE, Conquer JA. Effects of a stimulant-free dietary supplement on body weight and fat loss in obese adults: a six-week exploratory study. Curr Ther Res Clin Exp. 2003; 64(4): 248-262. Go to original source... Go to PubMed...
    16. Preuss HG, Bagchi D, Bagchi M, Rao CV, Dey DK, Satyanarayana S. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab. 2004; 6(3): 171-180. Go to original source...
    17. Al-Romaiyan A, Liu B, Asare-Anane H, Maity CR, Chatterjee SK, Koley N, Biswas T, Chatterji AK, Huang GC, Amiel SA, Persaud SJ, Jones PM. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010; 24(9):1370-1376. Go to original source...
    18. Kumar SN, Mani UV, Mani I. An open label study on the supplementation of Gymnema sylvestre in type 2 diabetics. J Diet Suppl. 2010; 7(3): 273-282. Go to original source... Go to PubMed...
    19. Kurian GA, Manjusha V, Nair SS, Varghese T, Padikkala J. Short-term effect of G-400, polyherbal formulation in the management of hyperglycemia and hyperlipidemia conditions in patients with type 2 diabetes mellitus. Nutrition. 2014; 30(10): 1158-1164. Go to original source...
    20. Zu?iga LY, González-Ortiz M, Martínez-Abundis E. Effect of Gymnema sylvestre Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion. J Med Food. 2017; 20(8): 750-754. Go to original source... Go to PubMed...
    21. Mills S, Bone K. The Essential Guide to Herbal Safety. Churchill Livingston 2004. 704 p.
    22. Vaghela M, Sahu N, Kharkar P, Pandita N. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats. Chem Biol Interact. 2017; 278: 141-151. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.